medroxyprogesterone has been researched along with Weight Loss in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Piper, A | 1 |
Lee-Chiong, TL; Qureshi, A | 1 |
Wang, H; Wang, J; Zhang, P | 1 |
Gastaldi, M; Genazzani, AD; Genazzani, AR; Petraglia, F; Surico, N; Volpogni, C | 1 |
HadaĆ, K; Halerz-Nowakowska, B; Maciejewska, M; Warenik-Szymankiewicz, A | 1 |
2 review(s) available for medroxyprogesterone and Weight Loss
Article | Year |
---|---|
Obesity hypoventilation syndrome: therapeutic implications for treatment.
Topics: Clinical Trials as Topic; Humans; Medroxyprogesterone; Obesity Hypoventilation Syndrome; Oxygen Inhalation Therapy; Positive-Pressure Respiration; Respiratory Insufficiency; Respiratory Mechanics; Risk Factors; Sleep Apnea, Obstructive; Weight Loss | 2010 |
Medical treatment of obstructive sleep apnea.
Topics: Antidepressive Agents; Continuous Positive Airway Pressure; Humans; Medroxyprogesterone; Phosphodiesterase Inhibitors; Posture; Respiratory System Agents; Sleep Apnea, Obstructive; Theophylline; Weight Loss | 2005 |
2 trial(s) available for medroxyprogesterone and Weight Loss
Article | Year |
---|---|
[A clinical trial Furlutal in the prevention of anorexia, weight loss and myelosuppression due to chemotherapy].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Medroxyprogesterone; Middle Aged; Weight Loss | 1995 |
Episodic release of prolactin in women with weight loss-related amenorrhea.
Topics: Amenorrhea; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone; Prolactin; Time Factors; Weight Loss | 1994 |
2 other study(ies) available for medroxyprogesterone and Weight Loss
Article | Year |
---|---|
[Repeated amenorrhea after body weight loss. Efficacy of treatment of estrogen and gestagen depending on the body mass index].
Topics: Amenorrhea; Body Mass Index; Dose-Response Relationship, Drug; Dydrogesterone; Estradiol; Female; Humans; Medroxyprogesterone; Progesterone Congeners; Time Factors; Treatment Outcome; Weight Loss | 1999 |
Medroxyprogesterone and palliative care: new indication. No impact on quality of life.
Topics: Antineoplastic Agents, Hormonal; Appetite; Appetite Stimulants; Clinical Trials as Topic; Humans; Medroxyprogesterone; Neoplasms; Palliative Care; Quality of Life; Treatment Outcome; Weight Loss | 2001 |